Helixgate https://validator.w3.org/feed/docs/rss2.html Team approach to lowering high blood pressure worked even in ‘a tough landscape’ STAT+: Influential Democratic think tank pushes plan for government to lower health care costs Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests Sidewinder secures $137M to advance ‘precision’ ADCs PhRMA head Steve Ubl to step down, according to sources With 3 quick buyouts, Gilead leans into its latest transformation Forecasting Protein Aggregation with an Improved Algorithm Activist investor revives campaign to overhaul Novavax board Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application STAT+: Terns’ drug may not be as competitive as many initially thought Gilead takes another big swing at expanding beyond HIV AC Immune and Lilly reach agreement on drug collaboration  Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities Inside the Talkspace-Universal Health Services deal Childhood Dementia Explained by Synaptic Dysfunction, Opens New Therapies 10 Companies Hiring in Texas Now STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make Headway David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapy What does MAHA look like these days? ADC biotech Sidewinder collects $137M for bispecific approach Medline hit with FDA warning letter over defective heart syringes, safety hazards Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma Insmed shelves Brinsupri in skin disease after mid-stage flop New Single‑Cell Platform Tracks RNA and Protein in Immune Signaling STAT+: A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope  Opinion: What American hospitals can learn from India about waste European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’ When a Good Boss Is Bad for Your Career As CGT Manufacturing Scales Up, Automation and Collaboration Become Essential Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company Scientists just uncovered the secret behind nature’s “proton highway” Activation mechanism and integrated one-pot assay of chiral-like cRNA-enhanced CRISPR/Cas12a systems Sequence Display enables large-scale sequence–activity datasets for rapid protein evolution Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review Neurocrine Grows in Endocrinology, Rare Disease with $2.9B Soleno Buyout Did Eli Lilly just strike another gold mine? White House adds AbbVie’s Humira to TrumpRx alongside cheaper biosimilars High-Throughput Platform for Fast-Acting Covalent Protein Therapies Terns rebuffed a higher bid before selling to Merck STAT+: Novo Nordisk launches high-dose Wegovy STAT+: States looking to regulate use of chatbots ARPA-H selects three teams in $100M effort to repair and regrow ailing joints Terns sold to Merck for 13% lower than pharma’s initial offer because of clinical data Autoimmune Disease-Related Inflammation Reduced with ENDOtollins Drug Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis Breaking through the undruggable barrier with TPDs STAT+: Pharmalittle: We’re reading about FDA backing domestic production, another Gilead deal, and more Home